Symptoms associated with rhesus-human reassortant rotavirus vaccine in infants

Pediatric Infectious Disease Journal

Volumn 17, Issue 4, 1998, Pages 334-340

  Joensuu, Jaana ^a,b   Koskenniemi, Eeva ^a   Vesikaei, Timo ^a  

^a UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Fever; Rhesus rotavirus; Rotavirus vaccine

Indexed keywords

DIPLOID CELL VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; RHESUS HUMAN REASSORTANT TETRAVALENT VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ABDOMINAL CRAMP; ANOREXIA; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FEVER; GASTROENTERITIS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; INFANT; IRRITABILITY; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ROTAVIRUS; SYMPTOMATOLOGY; VACCINATION;

ABDOMINAL PAIN; APPETITE; DIARRHEA; DOUBLE-BLIND METHOD; FEMALE; FEVER; HUMANS; INFANT; MALE; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINATION; VACCINES, ATTENUATED; VIRAL VACCINES; VOMITING;

EID: 0031968127     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199804000-00013     Document Type: Article

References (31)

1. Kapikian AZ. Jennerian and modified Jennerian approach to vaccination against rotavirus diarrhea in infants and young children: an introduction. In: Kapikian AZ, ed. Viral infections of the gastrointestinal tract. New York: Dekker, 1994: 409-17.
2. Vesikari T. Bovine rotavirus-based rotavirus vaccines in humans. In: Kapikian AZ, ed. Viral infections of the gastrointestinal tract. New York: Dekker, 1994:419-42.
3. Kapikian AZ. Rhesus rotavirus-based human rotavirus vaccines and observations on selected non-Jennerian approaches to rotavirus vaccination. In: Kapikian AZ, ed. Viral infections of the gastrointestinal tract. New York: Dekker, 1994:443-70.
4. Glass HI, Gentsch J, Smith JC. Rotavirus vaccines: success by reassortment. Science 1994;255:1389-91.
5. Vesikari T, Joensuu J. Review of rotavirus vaccine trials in Finland. J Infect Dis 1996;174(Suppl 1):S81-7.
6. Kapikian AZ, Hoshino Y, Chanock RM, Pérez-Schael I. Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children. J Infect Dis 1996;174(Suppl 1): S65-72.
7. Stuker G, Oshiro LS, Schmidt NL. Antigenic comparisons of two new rotaviruses from rhesus monkeys. J Clin Microbiol 1980;ll:202-3.
8. Midthun K, Greenberg HB, Hoshino Y, Kapikian AZ, Wyatt RG, Chanock RM. Reassortant rotaviruses as potential live rotavirus vaccine candidates. J Virol 1985;53:949-54.
9. Midthun K, Hoshino Y, Kapikian AZ, Chanock RM. Single gene substitution rotavirus reassortant containing the major neutralization protein (VP7) of human rotavirus serotype 4. J Clin Microbiol 1986;24:822-6.
10. Vesikari T, Vans T, Green K, Flores J, Kapikian AZ. Immunogenicity and safety of rhesus-human reassortant vaccines with serotype 1 or 2 VP7 specificity. Vaccine 1991;9:334-9.
11. Vesikari T, Kapikian AZ, Delem A, Zissis G. A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children. J Infect Dis 1985;153: 832-9.
12. Anderson EL, Belse RB, Bartram J, Crookshanks-Newman F, Chanock RM, Kapikian AZ. Evaluation of rhesus rotavirus vaccine (MMU 18006) in infants and young children. J Infect Dis 1985;153:823-31.
13. Losonsky GA, Rennels MB, Kapikian AZ, et al. Safety, infectivity, transmissibility, and immunogenicity of rhesus rotavirus vaccine (MMU 18006) in infants. Pediatr Infect Dis 1986;5:25-9.
14. Christy G, Madore HP, Treanor JJ, et al. Safety and immunogenicity of live attenuated rhesus monkey rotavirus vaccine. J Infect Dis 1986;154:1045-7.
15. Wright PJ, Tajima T, Thompson J, et al. Candidate rotavirus vaccine (rhesus rotavirus strain) in children: an evaluation. Pediatrics 1987;80:473-80.
16. Perez-Schael I, Gonzales M, Daoud N, et al. Reactogenicity and antigenicity of the rhesus rotavirus vaccine in Venezuelan children. J Infect Dis 1987;155:334-8.
17. Gothefors L, Wadell G, Juto P, Taniguchi K, Kapikian AZ, Glass RI. Prolonged efficacy of rhesus rotavirus vaccine in Swedish children. J Infect Dis 1989;159:753-7.
18. Christy C, Madore HP, Pichichero ME, et al. Field trial of rhesus rotavirus vaccine in infants. Pediatr Infect Dis J 1988;7:645-50.
19. Vesikari T, Rautanen T, Varis T, Beards GM, Kapikian AZ. Rhesus rotavirus candidate vaccine: clinical trial in children vaccinated between two and five months of age. Am J Dis Child 1990;144:285-9.
20. Rennels MB, Losonsky GA, Young AE, et al. An efficacy trial of rhesus rotavirus vaccine in Maryland. Am J Dis Child 1990;144:601-4.
21. Perez-Schael I, Blanco M, Vilar M, et al. Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants. J Clin Microbiol 1990;28:553-8.
22. Vesikari T, Ruuska T, Green KY, Flores J, Kapikian AZ. Protective efficacy against serotype l rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype l or 2 specificity. Pediatr Infect Dis J 1992;11:535-42.
23. Linhares AC, Gabbay YB, de Freitas RB, et al. Immunogenicity, safety and efficacy of rhesus-human reassortant rotavirus (RRV-TV-tetravalent) vaccine in Belern, Brazil. Bull World Health Organ 1996;74:491-500.
24. Lanata CF, Midthun K, Black RE, et al. Safety, immunogenicity, and protective efficacy of one and three doses of the tetravalent rhesus rotavirus vaccine in infants in Lima, Peru. J Infect Dis 1996;174:268-75.
25. Bernstein DI, Glass RI, Rodgers G, Davidson BL, Sack DA, for the US Rotavirus Vaccine Efficacy Group. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. JAMA 1995;273:1191-6.
26. Rennels MB, Glass RI, Dennehy PH, et al. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines: report of the National Multicenter Trial. Pediatrics 1996;97: 7-13.
27. Dennehy PH, Rodgers GC Jr., Ward RL, et al. Comparative evaluation of reactogenicity and immunogenicity of two dosages of oral tetravalent rhesus rotavirus vaccine. Pediatr Infect Dis J 1996;15:1012-8.
28. Joensuu J, Koskenniemi E, Pang XL, Vesikari T. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet 1997;350:1205-9.
29. Dagan R, Kassis I, Sarov B, et al. Safety and immunogenicity of oral tetravalent human-rhesus reassortant rotavirus vaccine in neonates. Pediatr Infect Dis J 1992;11:991-6.
30. Kapikian AZ, Hoshino Y, Flores J, et al. Alternative approaches to the development of a rotavirus vaccine. In: Holmgren J, Lindberg A, Möllby R, eds. Development of vaccines and drugs against diarrhea: 11th Nobel Conference, Stockholm, 1985. Lund, Sweden: Studentlitteratur, 1985:192-214.
31. Pérez-Schael I, Guntinas MJ, Pérez M, et al. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med 1997;337: 1181-7.